Cansino Biologics Stock Today
| CASBF Stock | USD 2.10 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 21
|
CanSino Biologics is trading at 2.10 as of the 24th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.1. CanSino Biologics has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for CanSino Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the Peoples Republic of China. Cansino Biologics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 114.78 M outstanding shares. More on CanSino Biologics
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CanSino Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CanSino Biologics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CanSino Biologics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) |
| Business Concentration | Soft Drinks, Beers, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
CanSino Biologics [CASBF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CanSino Biologics's market, we take the total number of its shares issued and multiply it by CanSino Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CanSino Biologics classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 114.78 M outstanding shares.
CanSino Biologics has accumulated about 7 B in cash with 2.05 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 28.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check CanSino Biologics Probability Of Bankruptcy
Ownership AllocationCanSino Biologics holds a total of 114.78 Million outstanding shares. CanSino Biologics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CanSino Ownership Details
CanSino Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of CanSino Biologics jumping above the current price in 90 days from now is about 50.0%. The CanSino Biologics probability density function shows the probability of CanSino Biologics pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon CanSino Biologics has a beta of -0.201 suggesting as returns on the benchmark increase, returns on holding CanSino Biologics are expected to decrease at a much lower rate. During a bear market, however, CanSino Biologics is likely to outperform the market. Additionally, canSino Biologics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of CanSino Biologics to move above the current price in 90 days from now is about 50.0 (This CanSino Biologics probability density function shows the probability of CanSino Pink Sheet to fall within a particular range of prices over 90 days) .
CanSino Biologics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. CanSino Biologics market risk premium is the additional return an investor will receive from holding CanSino Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CanSino Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although CanSino Biologics' alpha and beta are two of the key measurements used to evaluate CanSino Biologics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.13 | |||
| Standard Deviation | 3.04 | |||
| Variance | 9.25 | |||
| Risk Adjusted Performance | (0.02) |
CanSino Stock Against Markets
Picking the right benchmark for CanSino Biologics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CanSino Biologics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CanSino Biologics is critical whether you are bullish or bearish towards CanSino Biologics at a given time. Please also check how CanSino Biologics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in CanSino Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
CanSino Biologics Corporate Management
Elected by the shareholders, the CanSino Biologics' board of directors comprises two types of representatives: CanSino Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CanSino. The board's role is to monitor CanSino Biologics' management team and ensure that shareholders' interests are well served. CanSino Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CanSino Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yonghui Wu | VP Marketing | Profile | |
| Xuefeng Yu | Chairman, CoFounder | Profile | |
| Tao Zhu | Ex CoFounder | Profile | |
| Chunlin Xin | Director Department | Profile | |
| Xi Luo | Chief Officer | Profile | |
| FCS FCIS | Joint Sec | Profile | |
| Dongxu MBA | Exec CoFounder | Profile |
How to buy CanSino Pink Sheet?
Before investing in CanSino Biologics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in CanSino Biologics. To buy CanSino Biologics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of CanSino Biologics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase CanSino Biologics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located CanSino Biologics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased CanSino Biologics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as CanSino Biologics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in CanSino Biologics?
The danger of trading CanSino Biologics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CanSino Biologics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CanSino Biologics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CanSino Biologics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CanSino Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the CanSino Biologics information on this page should be used as a complementary analysis to other CanSino Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for CanSino Pink Sheet analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |